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were,” she said, “How separate we 
were from everyone who wasn’t 
part of the thing. There were the 
involved and uninvolved, and they 
just didn’t understand one an-
other.”
In July, a tape recording of 
these recollections, made a year 
before Wofsy’s death, was heard by 
17 doctors who had come togeth-
er in New York to commemorate 
the 25th anniversary of the first 
reported AIDS cases. The partici-
pants were among 76 first-genera-
tion AIDS doctors whom we had 
interviewed in the 1990s for an 
oral history documenting the U.S. 
epidemic.1 At the day-long July 
meeting, they looked back on their 
work, shared memories of the 
darkest years, recalled the exhil-
aration of the first prospects for 
effective AIDS treatment, and ru-
minated about who would step in 
to care for future patients.
The group vividly recalled per-
vasive institutional and profession-
al resistance to caring for patients 
with AIDS during the early 1980s. 
How could they explain why they 
had decided to take on this burden 
— a decision that had shaped 
their lives in unanticipated ways? 
At the time, most were young and 
beginning their careers, unencum-
bered by established commit-
ments. But there was more to it 
than that. For gay and lesbian doc-
tors, the suffering in their com-
munity provided sufficient moti-
vation. For others, the AIDS crisis 
tapped into long-held views about 
the social mission of medicine and 
the need to care for the marginal-
ized and despised. Wafaa El-Sadr, 
who developed the AIDS program 
at Harlem Hospital, said the epi-
demic had opened new worlds to 
her by demonstrating the impor-
tance of engaging in a genuine 
way with patients and drawing on 
their strengths.
Many felt compelled by geog-
raphy: being in New York, Los 
Angeles, San Francisco, or Miami 
made the epidemic hard to ignore. 
Pediatrician James Oleske remem-
bers feeling that in the impover-
ished community of Newark, New 
Jersey, he had no alternative but 
to care for babies and children 
with AIDS.
One thread that ran through 
the varied explanations was a deep 
sense of duty — of the doctor’s 
moral responsibility. In 1981, 
Molly Cooke, a San Francisco phy-
sician, was pregnant with her first 
child. Given how little was known 
about the risk of transmission, she 
was understandably fearful of tak-
ing on patients with AIDS. Yet she 
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recalled the way she and other physicians had been 
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remembered saying to her hus-
band, Paul Volberding, an oncol-
ogist who would help to shape 
San Francisco General Hospital’s 
response to AIDS, “If not us, who? 
What’s the justification for say-
ing someone else should do this?”
Whatever induced these phy-
sicians to make the initial 
commitment, perhaps a 
more difficult question is 
what sustained their en-
gagement in patient care 
and advocacy in an era 
when medicine was all but 
impotent against AIDS. 
Some, like Donna Mildvan, an in-
fectious-disease specialist in New 
York, felt a strong need to “bear 
witness; we were seeing stuff that 
nobody else in the world was see-
ing.” Through clinical treatment 
and careful observation, she be-
lieved, “We were going to solve 
this, and that was the commit-
ment that kept me alive and kick-
ing.” Volberding, for his part, felt 
the pull of treating a disease that 
constantly challenged his compe-
tence: “The thrill of this was the 
care of these patients; they need-
ed us so much. We couldn’t cure 
or treat HIV effectively, but we 
managed a lot of problems.”
Some credited the compelling 
characteristics of their patients 
with keeping them in the field. 
Pediatrician Hermann Mendez, 
who worked in Brooklyn, recalled, 
“You respected the people you were 
working with; you loved them, and 
you hated what was happening, 
and it was that love that kept you 
there and keeps me there.” Like 
Mendez, Gerald Friedland, who 
worked with drug users in the 
Bronx, remembered the emotion-
al draw: “The kind of suffering 
that people endured and the cour-
age that most of our patients ac-
tually had [were] extraordinary and 
inspired me.”
These physicians also found 
their commitment strengthened by 
the camaraderie that developed 
among them, fueled by mutual 
need and professional succor. Most 
recalled forming friendships with-
in the AIDS-care community be-
cause the “uninvolved” didn’t un-
derstand what they were doing or 
why they were doing it.
Their inability to change the 
course of the disease forced doc-
tors to seek other ways to meet 
patients’ needs. Today, more than 
a decade after the introduction of 
antiretroviral therapy transformed 
the landscape of AIDS treatment, 
the memories these pioneers re-
tain are vivid. Howard Grossman, 
who had a Manhattan-based pri-
vate practice for gay men, recalled, 
“We got thrown back to an ear-
lier time of medicine” — to an 
era when the doctor was more ma-
gician than scientist. Simple acts 
such as holding patients’ hands 
and listening to their stories were 
critical. Those who cared for poor 
patients, including drug users and 
their families, say the demands 
they confronted went far beyond 
the clinical interventions they had 
been trained to provide. Gwendo-
lyn Scott, a pediatric infectious-
disease specialist from Miami, 
remarked that she became a sort 
of social worker for affected fami-
lies: “They were living in cars, they 
didn’t have food, they didn’t have 
roofs over their heads. I couldn’t 
give them medical care when they 
didn’t have a place to live and food 
to put in their mouths.”
Of course, it was the tide of 
death during the epidemic’s early 
years that left the most haunting 
memories. Although he had tried 
“to take pain and put it back in 
its own compartment,” Volberding 
said, “there were horrible, horrible 
moments” during those years. Just 
as they strove to offer clinical care 
in the absence of effective medi-
cine, many sought, in Friedland’s 
words, “to arrange for a good 
death.” Mendez was brought to 
tears as he recalled a young girl 
in Brooklyn who had died in the 
hospital just 1 hour after a brief 
reunion with her imprisoned 
mother: “We learned the lesson 
the hard way, how to allow them 
to die at home in their room with 
their siblings, with everybody un-
derstanding what is going on. 
From then on, we didn’t and 
couldn’t allow anybody to die in 
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HIV touched something inside each of us that’s more than the profession that 
we chose. It might be that keen interest in people’s lives and wanting to talk to 
people and understand why they are what they are, and how they relate to their 
world, where they live, what they do. Maybe it was their stories. [In the early 
years] I was afraid that AIDS was just going to take over the world and what’s go-
ing to happen? What brought solace to our lives was talking to the patients and 
that optimism of how they struggled and how they dealt with this, and how we 
helped them deal with it. I think in a way that kept our fear in check.
— Wafaa El-Sadr, Mailman School of Public Health, 
Columbia University, and Harlem Hospital, New York
I was in Newark, New Jersey. I was committed to working in an under-
served area. I love children. All I remember was that there was one sick child 
after another coming in. It wasn’t a conscious decision that I wanted to work 
with AIDS or not work with AIDS. It was there, and you had to do it. 
You didn’t have a choice.
— James Oleske, New Jersey Medical School, 
University of Medicine and Dentistry of New Jersey, Newark
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the hospital.” El-Sadr recalled with 
anguish the surviving children of 
her patients and wondered what 
had happened to them. “Where 
are they now?” she asked. “Are 
they being taken care of? Are they 
healthy? Are they in jail?”
Commitments were tested in 
the late 1980s and early 1990s, not 
only by the emotional demands of 
a disease that mocked medicine’s 
therapeutic aspirations but also by 
the dashed hopes for progress in 
attacking the underlying cause of 
AIDS. It was hard to forget the 
exhilaration many had felt when 
zidovudine (earlier known as azido-
thymidine, or AZT), the first an-
tiretroviral drug, seemed to be 
effective. Alexandra Levine, an on-
cologist from Los An-
geles, remembered a 
patient who had called 
because he had sur-
vived to celebrate his 
birthday. But it was 
also hard to forget the 
despair of learning 
that AZT’s benefits 
were limited. Mildvan 
said she found the experience per-
sonally painful and “professionally 
humbling.”
With the development of effec-
tive antiretroviral therapy in the 
mid-1990s, many saw AIDS as 
having been normalized, rendered 
just another chronic disease. The 
crisis that had drawn these doc-
tors and sustained their sense of 
mission had passed. For a few pi-
oneers, this sense of mission re-
tains something of its original 
excitement. Mildvan, for example, 
said, “This has never been a bor-
ing disease; it keeps evolving into 
new questions.” Others, however, 
see the epidemic against which 
they struggled as fundamentally 
changed. AIDS care, observed 
Donna Futterman, a New York–
based specialist in adolescent med-
icine, is now “about managing 
extremely technical combinations 
of doses” — a far cry from the 
multidisciplinary demands that 
once seemed to mean that “to 
know HIV was to know society.” 
Friedland registered the irony: “It’s 
clear that something has been lost. 
Honestly, at this point I miss it, 
even though I never thought I 
would, with all the death and dy-
ing.” Nothing underscored this 
ironic sense of nostalgia more dra-
matically than the startling an-
nouncement by Donald Abrams, 
a prominent gay physician and 
researcher in San Francisco, that 
he would be leaving HIV medicine 
imminently because it no longer 
spoke to his “need to be a healer.”
Many of these pioneers feel that 
something has gone awry, and 
they despair about the next gen-
eration. “I’m not finding a lot of 
medical students and residents 
who want to do what I do,” said 
Oleske. “They actually say, ‘This 
isn’t for me.’ I don’t know how 
we’re going to change that, but I 
worry very much.” The sense of 
urgency that drew Oleske and his 
generation to the care of patients 
with AIDS in its early years no 
longer defines the world encoun-
tered by young doctors.
Some veterans of the U.S. ep-
idemic have found their idealism 
revitalized by a commitment to 
the global epidemic. El-Sadr, for 
example, who has thrown herself 
into the struggle against AIDS in 
southern Africa, is “driven to make 
it happen there for all those peo-
ple like we really did here. There 
are so many more similarities be-
tween Harlem and Maputo than 
there are between Harlem and 
San Francisco.”
For others, the shifting of at-
tention to the global epidemic im-
plies that the challenge at home is 
no longer compelling. Oleske con-
fronted that position directly, re-
minding his colleagues that AIDS 
remains embedded in America’s 
poorest communities. “I’m not 
here to celebrate that HIV is over,” 
he concluded. “In Newark, New 
Jersey, AIDS is alive and well.”
An interview with Drs. El Sadr and Oleske 
can be heard at www.nejm.org.
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A patient of mine was admitted, blind and demented, because his AZT had worn 
off. I think that was the most depressing, horrifying experience of my whole 
career — having gone on that roller coaster, having been so excited, it was as if 
the whole bottom was just ripped out from under me, and  there was nothing in 
sight that was really going to alter this.
 
— Donna Mildvan, Beth Israel Medical Center, New York
HIV care doesn’t grab me and doesn’t move me and doesn’t excite me or challenge 
me the way it used to. So I, in fact, will be seeing my last HIV clinic on August 8, and 
I will no longer be doing HIV research or care. I’m happy for the patients, fortunately, 
that you can see them and say, “I’ll see you in 4 months. Here’s your lab slip. Here’s 
your prescription refill.” But for me, that doesn’t speak to my need to be a healer, 
and it doesn’t excite me the way it did at the very beginning, when there was so 
much uncertainty.
— Donald Abrams, San Francisco General Hospital, 
University of California, San Francisco
